Search alternatives:
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 321 - 340 results of 121,608 for search '(( 5 ((((nm decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 2 e decrease ))', query time: 1.64s Refine Results
  1. 321
    Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1.

    Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

    Published 2014
    “…Scale bar, 2 microns. Data shown are mean values ± SD, <i>p</i><0.01. …”
    Save to List
    Saved in:
  2. 322
    Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia.

    Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

    Published 2025
    Save to List
    Saved in:
  3. 323
    In the absence of chloride, two-fold decrease in [Na<sup>+</sup>]<sub>e</sub> shifted GLT-1a E<sub>rev</sub> by −28 mV at both low and high glutamate concentrations.

    In the absence of chloride, two-fold decrease in [Na<sup>+</sup>]<sub>e</sub> shifted GLT-1a E<sub>rev</sub> by −28 mV at both low and high glutamate concentrations. by Anatoli Y. Kabakov (729047)

    Published 2015
    “…<b>(D)</b> Average E<sub>rev</sub> shifts at [Glu<sup>-</sup>]<sub>e</sub> geometric means of 37.5 and 600 μM are approximately equal when [Na<sup>+</sup>]<sub>e</sub> was decreased from 102 to 51 mM. …”
    Save to List
    Saved in:
  4. 324
    Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia.

    Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

    Published 2025
    Save to List
    Saved in:
  5. 325
    Decrease of receptor detectibility following CRAD replication in a small fraction of cells.

    Decrease of receptor detectibility following CRAD replication in a small fraction of cells. by Johan Rebetz (255622)

    Published 2009
    Save to List
    Saved in:
  6. 326
    Gefitinib and erlotinib decreased cyclin-D1 without activation of caspase-3.

    Gefitinib and erlotinib decreased cyclin-D1 without activation of caspase-3. by Satoshi Koyama (784927)

    Published 2015
    Save to List
    Saved in:
  7. 327
    Decrease of goblet cells in mice fed a high-fat diet (HFD).

    Decrease of goblet cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

    Published 2017
    Save to List
    Saved in:
  8. 328
    Decrease of Paneth cells in mice fed a high-fat diet (HFD).

    Decrease of Paneth cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

    Published 2017
    Save to List
    Saved in:
  9. 329
    PV1-treated mice exhibited a decrease in overall activation of T lymphocytes.

    PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

    Published 2017
    Save to List
    Saved in:
  10. 330
    Coibamide A induces a time- and concentration-dependent decrease in plasma membrane integrity.

    Coibamide A induces a time- and concentration-dependent decrease in plasma membrane integrity. by Andrew M. Hau (418935)

    Published 2013
    Save to List
    Saved in:
  11. 331
    V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells.

    V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

    Published 2008
    Save to List
    Saved in:
  12. 332
    Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection.

    Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

    Published 2024
    Save to List
    Saved in:
  13. 333
    Administration of γPGA attenuates Th2 immune responses elicited by the cysteine protease papain through a decrease in basophils.

    Administration of γPGA attenuates Th2 immune responses elicited by the cysteine protease papain through a decrease in basophils. by Hyun Jung Park (116737)

    Published 2016
    Save to List
    Saved in:
  14. 334
    Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice.

    Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

    Published 2018
    Save to List
    Saved in:
  15. 335
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 336
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 337
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 338
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 339
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 340
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: